Prognostic Factors in Patients with Acute Myeloid Leukemia Treated with the Combination of Venetoclax plus Azacitidine(VEN+AZA).
Year: 2024
Type: article
Study design: Observational Study
Source: PubMed
Authors: Yasunobu Sekiguchi, Hiroki Tsutsumi, Masahisa Kudo, Nobuo Maseki, Yoshie Iizaki, Machiko Kawamura, Kazuhiko Kobayashi, Tomoya Abe, Daisuke Takei, Yu Nishimura, Hiroaki Kanda, Masaaki Noguchi, Hirofumi Kobayashi
Institution: Saitama Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4405204028